Journal article · 2026 · Open access
Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard
Clinical Pharmacology & Therapeutics · Published 8 November 2026 · DOI 10.1002/cpt.70557
In brief
“Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard” is a 2026 journal article by John D. Schuetz and Richard B. Kim, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 16 November 2026. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 0
- References
- 10
- Authors
- 2
Abstract
Genomic findings can sharpen therapeutic decisions, but they can also provide false reassurance. In precision oncology, labels such as benign, nonactionable, or explanatory may be mistaken for evidence that symptoms or abnormal findings require no further evaluation. This Perspective argues that genotype-phenotype discordance should be treated as a safety signal. Simple report language, tumor-board checks, and artificial intelligence guardrails can preserve the value of genomics without allowing a molecular explanation to become diagnostic closure.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Schuetz, J. D., & Kim, R. B. (2026). Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70557
MLA 9
Schuetz, John D., and Richard B. Kim. “Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70557.
Chicago
Schuetz, John D. and Richard B. Kim. 2026. “Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70557.
Harvard
Schuetz, J. D. and Kim, R. B. (2026) ‘Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70557.
IEEE
J. D. Schuetz and R. B. Kim, “Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70557.
BibTeX
@article{schuetz2026genomic,
title = {{Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard}},
author = {Schuetz, John D. and Kim, Richard B.},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70557},
url = {https://doi.org/10.1002/cpt.70557}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- precision oncology
- genotype-phenotype discordance
- safety signals
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Schuetz, J. D., & Kim, R. B. (2026). Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70557
How many times has this paper been cited?
0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
John D. Schuetz, Richard B. Kim.
What is the DOI of this paper?
10.1002/cpt.70557, permanently at https://doi.org/10.1002/cpt.70557. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.